LexDanaLexDanabeta
Inventor

Peter BUNYARD

Inventor
GB

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,453,734Modulators of rho-associated protein kinase202511,878,020Modulators of Rho-associated protein kinase202411,497,751Modulators of Rho-associated protein kinase2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to REDX PHARMA PLC (2)· patent assignee history
2022–2025Based in GB· patent location history
2025Patents assigned to REDX PHARMA LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REDX PHARMA PLC22022–2024
REDX PHARMA LTD12025
Locations
LocationPatentsSpan
GB32022–2025